3M Co (MMM) stock
MMMNYSESurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 20, 2026Score 14/3020% above fair value
$186.24−2.64 (-1.40%)
Close on Nov 12, 2026Market cap $96.24BP/E 27.8Yield 1.57%
3M ebitda
EBITDA is earnings before interest, taxes, depreciation and amortization, a rough measure of cash profit from operations.
3M's ebitda for the twelve months ending Sep 30, 2026 was $6.16B, up 0.7% year over year. For fiscal 2025 it was $5.94B, down 4.0% from the year before. Over ten years it grew -3.4% a year on average. The highest annual figure on record is $9.28B in fiscal 2021.
Annual ebitda
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $5.94B | -4.0% |
| FY2024 | Dec 31, 2024 | $6.19B | – |
| FY2023 | Dec 31, 2023 | -$8.70B | -240.4% |
| FY2022 | Dec 31, 2022 | $6.20B | -33.2% |
| FY2021 | Dec 31, 2021 | $9.28B | +2.3% |
| FY2020 | Dec 31, 2020 | $9.07B | +16.8% |
| FY2019 | Dec 31, 2019 | $7.77B | -10.7% |
| FY2018 | Dec 31, 2018 | $8.70B | -5.9% |
| FY2017 | Dec 31, 2017 | $9.24B | +8.6% |
| FY2016 | Dec 31, 2016 | $8.50B | +1.4% |
| FY2015 | Dec 31, 2015 | $8.38B | -1.9% |
| FY2014 | Dec 31, 2014 | $8.54B | +6.3% |
| FY2013 | Dec 31, 2013 | $8.04B | +3.4% |
| FY2012 | Dec 31, 2012 | $7.77B | +4.8% |
| FY2011 | Dec 31, 2011 | $7.41B | +5.3% |
| FY2010 | Dec 31, 2010 | $7.04B | +17.9% |
| FY2009 | Dec 31, 2009 | $5.97B | -6.3% |
| FY2008 | Dec 31, 2008 | $6.37B | -12.3% |
| FY2007 | Dec 31, 2007 | $7.27B | – |
Quarterly ebitda
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | $1.89B | +8.5% |
| Q2 FY2026 | Jun 30, 2026 | $1.32B | -7.8% |
| Q1 FY2026 | Mar 31, 2026 | $1.72B | +12.2% |
| Q4 FY2025 | Dec 31, 2025 | $1.23B | -12.9% |
| Q3 FY2025 | Sep 30, 2025 | $1.75B | +7.3% |
| Q2 FY2025 | Jun 30, 2025 | $1.43B | -9.1% |
| Q1 FY2025 | Mar 31, 2025 | $1.54B | -2.7% |
| Q4 FY2024 | Dec 31, 2024 | $1.41B | -2.0% |
| Q3 FY2024 | Sep 30, 2024 | $1.63B | – |
| Q2 FY2024 | Jun 30, 2024 | $1.57B | – |
| Q1 FY2024 | Mar 31, 2024 | $1.58B | -7.5% |
| Q4 FY2023 | Dec 31, 2023 | $1.44B | – |
| Q3 FY2023 | Sep 30, 2023 | -$2.56B | -155.6% |
| Q2 FY2023 | Jun 30, 2023 | -$8.91B | -1657.5% |
| Q1 FY2023 | Mar 31, 2023 | $1.71B | -18.7% |
| Q4 FY2022 | Dec 31, 2022 | -$1.08B | -150.8% |
| Q3 FY2022 | Sep 30, 2022 | $4.61B | +103.4% |
| Q2 FY2022 | Jun 30, 2022 | $572.00M | -76.6% |
| Q1 FY2022 | Mar 31, 2022 | $2.10B | -14.4% |
| Q4 FY2021 | Dec 31, 2021 | $2.12B | -9.5% |
| Q3 FY2021 | Sep 30, 2021 | $2.26B | -5.3% |
| Q2 FY2021 | Jun 30, 2021 | $2.44B | +9.5% |
| Q1 FY2021 | Mar 31, 2021 | $2.45B | +16.7% |
| Q4 FY2020 | Dec 31, 2020 | $2.35B | +31.3% |
| Q3 FY2020 | Sep 30, 2020 | $2.39B | 0.0% |
| Q2 FY2020 | Jun 30, 2020 | $2.23B | +7.4% |
| Q1 FY2020 | Mar 31, 2020 | $2.10B | +39.2% |
| Q4 FY2019 | Dec 31, 2019 | $1.79B | -17.0% |
| Q3 FY2019 | Sep 30, 2019 | $2.39B | +0.8% |
| Q2 FY2019 | Jun 30, 2019 | $2.08B | -25.3% |
| Q1 FY2019 | Mar 31, 2019 | $1.51B | +8.8% |
| Q4 FY2018 | Dec 31, 2018 | $2.15B | +0.7% |
| Q3 FY2018 | Sep 30, 2018 | $2.37B | -0.6% |
| Q2 FY2018 | Jun 30, 2018 | $2.78B | +9.8% |
| Q1 FY2018 | Mar 31, 2018 | $1.39B | -36.3% |
| Q4 FY2017 | Dec 31, 2017 | $2.14B | +15.4% |
| Q3 FY2017 | Sep 30, 2017 | $2.39B | – |
| Q2 FY2017 | Jun 30, 2017 | $2.53B | – |
| Q1 FY2017 | Mar 31, 2017 | $2.18B | – |
| Q4 FY2016 | Dec 31, 2016 | $1.85B | – |
See a number that looks wrong?